In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Albemarle's current price exceeds the PERT-weighted fair value by 9.7%, indicating potential overvaluation with mixed valuation signals: negative DCF versus high analyst targets. Strong liquidity and growth contrast sharply with zero profitability and efficiency scores, implying elevated operational risks. Monte Carlo analysis shows no downside scenarios below current price, suggesting limited near-term risk.